MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-11-30, NRIX made $83,980K in revenue. -$264,457K in net income. Net profit margin of -314.90%.

Income Overview

Revenue
$83,980K
Net Income
-$264,457K
Net Profit Margin
-314.90%
EPS
-$3.05
Unit: Thousand (K) dollars
Revenue Breakdown
    • Collaboration Revenue
    • License Revenue

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-11-30
Total revenue
83,980
Research and development
316,903
General and administrative
52,743
Total operating expenses
369,646
Loss from operations
-285,666
Interest and other income, net
21,969
Loss before income taxes
-263,697
Provision for income taxes
760
Net loss
-264,457
Net loss per share, basic (in usd per share)
-3.05
Net loss per share, diluted (in usd per share)
-3.05
Weighted-average number of shares outstanding, basic (in shares)
86,666,907
Weighted-average number of shares outstanding, diluted (in shares)
86,666,907
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$264,457K Provision for income taxes$760K Loss before incometaxes-$263,697K Interest and otherincome, net$21,969K License Revenue$30,000K Collaboration Revenue$53,980K Loss from operations-$285,666K Total revenue$83,980K Total operatingexpenses$369,646K General andadministrative$52,743K Research and development$316,903K

Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics, Inc. (NRIX)